The Most Important Advances in Precision Medicine Being Presented at ASCO 2018

David Spigel, MD

Video Categories: 2018 ASCO Insights, Biomarkers, and Video Library

Dr David Spigel reviews 3 of the most important, practice-changing topics at ASCO 2018: new therapies targeting RET in a number of tumor types, a prognostic biomarker assay to predict whether patients with breast cancer will need adjuvant hormonal therapy or chemotherapy, and the minimum level of PD-L1 positivity required to predict outcomes with immunotherapy in lung cancer.

July 29, 2015

Targeted Therapies and their Impact on Melanoma

Dr. Steve O’Day works with melanoma and has seen great breakthroughs in targeted therapies and their impact on the disease.

November 24, 2014

Is Research Translating to Meaningful Treatment to Patients?

Dr. Palmer describes how the direct relationship between treatment directed to change in the DNA actually affects the outcome of patients.